Carroll Investors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-869
Closed -$288K 34
2025
Q4
$288K Buy
+869
New +$294K 0.14% 27
2025
Q2
Sell
-443
Closed -$230K 34
2025
Q1
$230K Sell
443
-830
-65% -$424K 0.15% 28
2024
Q4
$646K Buy
1,273
+809
+174% +$460K 0.36% 21
2024
Q3
$270K Sell
464
-5
-1% -$2.83K 0.18% 24
2024
Q2
$333K Hold
469
0.23% 20
2024
Q1
$232K Hold
469
0.17% 22
2023
Q4
$246K Sell
469
-44
-9% -$23.5K 0.2% 20
2023
Q3
$261K Sell
513
-122
-19% -$60K 0.23% 23
2023
Q2
$304K Sell
635
-687
-52% -$336K 0.23% 25
2023
Q1
$623K Hold
1,322
0.51% 26
2022
Q4
$701K Hold
1,322
0.74% 23
2022
Q3
$670K Buy
1,322
+809
+158% +$425K 0.54% 21
2022
Q2
$263K Hold
513
0.24% 28
2022
Q1
$260K Sell
513
-169
-25% -$81.5K 0.17% 30
2021
Q4
$341K Buy
+682
New +$309K 0.19% 30

Other funds holding UNH

Carroll Investors's UNH Position: Q1 2026 in Review

Carroll Investors sold out of UnitedHealth (UNH) in Q1 2026, closing a stake of 869 shares — an estimated $288K sold.

Carroll Investors first reported a position in UNH in Q4 2021 and held it in 15 quarters. The position peaked at $701K in Q4 2022. 3,024 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Carroll Investors reported no remaining UnitedHealth position as of Q1 2026 after selling out during the quarter.
  • Carroll Investors sold 869 UnitedHealth shares in Q1 2026, an estimated $288K.
  • Carroll Investors first reported a position in UnitedHealth in Q4 2021 and held it in 15 quarters.
  • Carroll Investors's UnitedHealth position peaked at $701K in Q4 2022.
  • 3,024 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Carroll Investors's 13F filing for Q1 2026, filed 15 May 2026.